CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03475953
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:17.302238+00:00
Published At: 2023-03-03T00:00:00+00:00
Record Updated At: 2023-03-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Colorectal Cancer Not MSI-H or MMR-deficient", "GIST", "Oesophageal or Gastric Carcinoma", "Biliary Tract Cancer", "Hepatocellular Carcinoma", "Soft-tissue Sarcoma", "Thyroid Cancer", "Gastro-enteropancreatic Neuroendocrine Tumor", "Non-small Cell Lung Cancer", "Solid Tumor, Adult", "Urothelial Carcinoma", "HPV-Related Carcinoma", "Triple Negative Breast Cancer", "Renal Carcinoma", "Mesotheliomas Pleural"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-03-03"
protocolSection.identificationModule.nctId: "NCT03475953"
protocolSection.identificationModule.officialTitle: "A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.